Skip to main content

Table 1 The correlation of ZNF880 with the prognosis of CRC patients in the GSE17536, GSE14333, and GSE17537 data sets

From: Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer

ID_NAME

DATASET

CANCER TYPE

ENDPOINT

COHORT

PROBE ID

P-VALUE

ZNF880

GSE17536

CRC

OS

MCC

232315_at

0.055368

ZNF880

GSE17536

CRC

DSS

MCC

232315_at

0.045468

ZNF880

GSE17536

CRC

OS

MCC

235913_at

0.015079

ZNF880

GSE17536

CRC

DSS

MCC

235913_at

0.007958

ZNF880

GSE17536

CRC

DFS

MCC

232315_at

0.002737

ZNF880

GSE17536

CRC

DFS

MCC

235913_at

0.03615

ZNF880

GSE14333

CRC

DFS

Melbourne

232315_at

0.023111

ZNF880

GSE14333

CRC

DFS

Melbourne

235913_at

0.022737

ZNF880

GSE17537

CRC

OS

VMC

232315_at

0.046462

ZNF880

GSE17537

CRC

OS

VMC

235913_at

0.037382

ZNF880

GSE17537

CRC

DFS

VMC

232315_at

0.005318

ZNF880

GSE17537

CRC

DFS

VMC

235913_at

0.018586

ZNF880

GSE17537

CRC

DSS

VMC

232315_at

0.037554

ZNF880

GSE17537

CRC

DSS

VMC

235913_at

0.020751